1. [P1–056]: POPULATION PHARMACOKINETIC‐PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS. (1st July 2017) Authors: Schuck, Edgar L.; Lai, Robert Y.K.; Aluri, Jagadeesh; Hussein, Ziad; Ino, Mitsuhiro; Kotani, Sadaharu; Chang, Min‐Kun; Savant‐Landry, Ishani; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy. (April 2019) Authors: Renfroe, J. Ben; Mintz, Mark; Davis, Ronald; Ferreira, Jose; Dispoto, Sharon; Ferry, Jim; Umetsu, Yuko; Rege, Bhaskar; Majid, Oneeb; Hussein, Ziad; Laurenza, Antonio Journal: Journal of child neurology Issue: Volume 34:Number 5(2019:May) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of morning sleep propensity with lemborexant in adults with insomnia disorder in a randomized, placebo-controlled crossover study. Issue 1 (2nd July 2021) Authors: Mayleben, David; Rosenberg, Russell; Pinner, Kate; Hussein, Ziad; Moline, Margaret Journal: Sleep advances Issue: Volume 2:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma. (9th June 2021) Authors: Hussein, Ziad; Korbonits, Marta; Baldeweg, Stephanie E; Chung, Teng-Teng Journal: Endocrinology, diabetes & metabolism case reports Issue: (2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation. (11th June 2020) Authors: Schuck, Edgar; Ferry, Jim; Gidal, Barry; Hussein, Ziad Journal: Acta neurologica Scandinavica Issue: Volume 142:Number 2(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizures. Issue 8 (17th June 2013) Authors: Gidal, Barry E.; Ferry, Jim; Majid, Oneeb; Hussein, Ziad Journal: Epilepsia Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. (17th January 2023) Authors: Lalovic, Bojan; Savant Landry, Ishani; Moline, Margaret; Reyderman, Larisa; Hussein, Ziad Journal: Journal of clinical pharmacology Issue: Volume 63:Number 4(2023) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers. Issue 4 (11th October 2022) Authors: Yamakawa, Naoto; Tago, Fumitoshi; Nakai, Kenya; Kitahara, Yasumi; Ikari, Shingo; Hojo, Seiichiro; Hall, Nancy; Aluri, Jagadeesh; Hussein, Ziad; Gevorkyan, Hakop; Maruyama, Tatsuya; Ishizaka, Sally; Yagi, Takuya Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 4(2023) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗